申请人:Merck & Co., Inc.
公开号:US06432976B1
公开(公告)日:2002-08-13
Novel 3-substituted 8-aza-bicyclo[3.2.1]octanes (commonly known as “tropanes”) substituted in the 8-position are effective as NMDA NR2B antagonists useful for relieving pain.
小说中3-取代的8-氮杂双环[3.2.1]辛烷(通常称为“托帕因”)在8位取代的情况下,可作为NMDA NR2B拮抗剂,有助于缓解疼痛。